Eli Lilly weight loss drug cuts risk of developing diabetes in trial
Eli Lilly’s highly popular weight loss drug reduced the risk of developing Type 2 diabetes by 94% in obese or overweight adults with
[...]
David A. Ricks
Eli Lilly (LLY) earnings Q2 2024
Eli Lilly on Thursday reported second-quarter earnings and revenue that blew past expectations and hiked its full-year revenue outlook by $3 billion as
[...]
